ZAVESCA

Identification of Zavesca

No description

Google image searchProduct monograph

Active ingredient

miglustat, 100 MG

DIN: 02250519

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: JANSSEN INC

Date: 04-FEB-2020

ATC:

• A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
• A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
• A16AX — Various alimentary tract and metabolism products (ATC, ATC/DDD)
• A16AX06 — MIGLUSTAT (ATC/DDD)

Reference brand drug: Zavesca

External Links for Zavesca

Search on Google

• Zavesca side effects
• Zavesca dosage
• miglustat side effects
• miglustat dosage

Janssen Inc

Go to Janssen website to see drug product details. Sometimes you can find zavesca photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.